Skip to content
Search

Latest Stories

Alliance Healthcare UK supports 'Medicines to Ukraine' campaign

Alliance Healthcare UK has supported the Medicine to Ukraine campaign through its distribution network; via a coordinated, country-wide poster drop to UK pharmacy stores.

The Medicines to Ukraine pharmacy appeal is led by the Healthcare Distribution Association (HDA), Pharmacists' Defence Association (PDA), and National Pharmacy Association (NPA) in the UK, who are urging pharmacy teams to promote the campaign to customers and members of the public to raise funds.


Over 15,000 Medicines to Ukraine posters have been delivered to pharmacies across the UK. The posters are already in pharmacy windows across Europe raising awareness of the campaign.

The Medicines to Ukraine campaign is part of a pan-European effort established by Employed Pharmacists in Europe (EPhEU). The campaign procures and sends specialist hospital medicines that are running low or that are no longer available in Ukraine directly to Ukrainian hospitals that are treating the casualties of the war.

Roughly £220,000 has been raised via the appeal in the UK alone and a total of £3 million has been raised across Europe to date.

Martin Sawer, Executive Director of HDA commented: “Our member companies’ distribution networks ensure a comprehensive, resilient and efficient supply system is always there for community pharmacies, hospitals and dispensing doctors. The Association is delighted that an HDA distributor is making use of its own intensive national network to enable this vital campaign.”

Matt Addison, Operations Director at Alliance Healthcare, said: “Each of the 16,500 pharmacies that we supply each day will play an important role in raising awareness of the Medicines to Ukraine campaign. Alliance Healthcare is fortunate to have an operation ready to help our pharmacy customers activate this important appeal and play its part to help those impacted by the war in Ukraine.”

Alliance Healthcare has previously supported on several similar leaflets drops in support of pharmacy, campaigns including the NHS "Stay Well This Winter" campaign.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less